Teva Pharmaceutical Industries (TEVA)

Teva Pharmaceutical Industries on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.

Download CSV

Short interest in Teva Pharmaceutical Industries (TEVA) was 27.7 million shares at the 30 October 2026 settlement, down 1.2% from the 15 October 2026 settlement, with days to cover at 5.3. In the last 90 days Teva Pharmaceutical Industries insiders reported 18 open-market sales and no purchases, net sales of $33.9 million. The largest was a sale of 367,600 shares worth $14.4 million by MIGNONE ROBERTO (Director) on 18 September 2026. The next earnings report for Teva Pharmaceutical Industries is estimated for 27 January 2027.

27.7M

Short interest

settlement 2026-10-30

5.3

Days to cover

+1.4 days vs prior

19.2%

Short share of volume

2026-11-12

1,209

Fails to deliver

settlement 2026-10-13

Wed 27 Jan

Next earnings

estimated date

-$33.9M

Insider flow, 90 days

0 buys, 18 sells

As of 2026-11-12.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 October 2026, short interest in TEVA is 27,739,194 shares, down 2,109,611 shares over the last month. Over the last 48 readings it ranged from 15,797,023 shares (15 January 2025) to 55,193,262 shares (15 September 2025). At the reported average volume of 5.2M shares a day that is 5.3 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/teva" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-3027,739,194-1.2%5,232,3285.30
2026-10-1528,070,513-6.0%7,162,0263.92
2026-09-3029,848,805-5.2%5,530,3895.40
2026-09-1531,478,314+11467.5%1,150,99227.35
2026-08-3137,614,253+5.5%4,877,0297.71
2026-08-1435,670,864+3.9%5,379,1816.63
2026-07-3134,320,980+4.8%5,976,5635.74
2026-07-1532,741,011+2.2%5,031,8246.51
2026-06-3032,029,657-4.0%6,283,3265.10
2026-06-1533,346,891-1.5%6,149,2165.42
2026-05-2933,869,008+27.1%5,646,5106.00
2026-05-1526,651,458-14.4%6,682,3653.99
2026-04-3031,140,457+4.7%7,780,7944.00
2026-04-1529,736,398+10.0%4,191,1687.10
2026-03-3127,042,748-28.1%7,063,6693.83
2026-03-1337,623,025+15.7%8,864,2214.24
2026-02-2732,527,649-11.2%6,457,3365.04
2026-02-1336,644,722-3.5%10,104,6943.63
2026-01-3037,953,087+15.1%10,894,4193.48
2026-01-1532,969,413+0.3%11,356,2322.90
2025-12-3132,862,069-26.9%6,967,0494.72
2025-12-1544,936,239-1.5%10,908,9594.12
2025-11-2845,620,941-1.8%10,577,4864.31
2025-11-1446,443,487-7.8%18,429,8772.52
2025-10-3150,392,932+6.6%8,663,0705.82
2025-10-1547,284,149-5.2%8,949,2855.28
2025-09-3049,879,298-9.6%11,232,7964.44
2025-09-1555,193,262+9.3%10,307,4815.35
2025-08-2950,507,199+9.2%10,749,8754.70
2025-08-1546,260,428-7.3%11,244,1614.11
2025-07-3149,888,340-6.6%13,514,2493.69
2025-07-1553,422,754+34.0%9,928,5285.38
2025-06-3039,866,309-0.3%10,464,2303.81
2025-06-1339,997,484+12.1%10,873,9033.68
2025-05-3035,668,065-7.8%11,079,3553.22
2025-05-1538,696,395+36.1%16,418,9232.36
2025-04-3028,426,081-6.3%10,080,2512.82
2025-04-1530,337,658-6.3%13,762,6292.20
2025-03-3132,386,482-6.9%9,926,9213.26
2025-03-1434,801,653+25.1%13,876,1902.51
2025-02-2827,808,217+4.3%12,103,8592.30
2025-02-1426,656,344+19.2%12,530,7552.13
2025-01-3122,360,234+41.5%15,771,4731.42
2025-01-1515,797,023-41.8%9,865,5381.60
2024-12-3127,132,150+16.9%14,661,1861.85
2024-12-1323,220,122+3.6%7,827,7072.97
2024-11-2922,407,656+5.7%8,347,4332.68
2024-11-1521,191,235+17.1%8,453,0112.51

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 12 November 2026, the short share of TEVA volume is 19.2%, up 4.0 points over the last five sessions. Over the last 30 readings it ranged from 15.2% (5 November 2026) to 56.9% (7 October 2026). The latest reading sits at the bottom of that range. The latest reading is 14.3 points below the 30-session average of 33.5%, on 4.2M shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-12805K4.2M19.2%718
2026-11-11664K3.6M18.5%287
2026-11-10469K3.1M15.2%5,768
2026-11-09609K2.0M30.4%5,620
2026-11-06637K2.3M28.0%1,052
2026-11-05815K5.4M15.2%6,943
2026-11-041.3M4.2M30.8%21
2026-11-031.7M4.8M36.0%4,090
2026-11-021.4M3.1M45.0%722
2026-10-30950K3.2M30.0%10,580
2026-10-29556K2.1M26.2%703
2026-10-28632K1.6M39.0%20
2026-10-27377K1.6M23.4%100
2026-10-26418K2.3M18.2%3,806
2026-10-23226K1.5M15.2%203
2026-10-22578K1.8M31.7%2,701
2026-10-21781K1.8M43.9%9,854
2026-10-20606K1.6M37.7%2,251
2026-10-19557K1.3M44.5%1,164
2026-10-16953K2.9M33.3%409
2026-10-151.2M3.6M34.8%0
2026-10-141.7M4.0M41.9%1,084
2026-10-131.3M2.9M43.3%311
2026-10-121.4M3.0M45.6%1,335
2026-10-092.8M7.8M36.2%6,828
2026-10-081.4M3.2M42.9%0
2026-10-07670K1.2M56.9%512
2026-10-061.2M3.0M40.1%101
2026-10-05517K1.6M33.1%2,528
2026-10-02892K1.8M48.5%712

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 13 October 2026, the fails-to-deliver balance in TEVA is 1,209 shares, up 1,203 shares over the last settlement date. Over the last 30 readings it ranged from 6 shares (9 October 2026) to 443,776 shares (25 September 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-131,209$41.17$50K
2026-10-096$39.25$236
2026-10-06189$39.66$7K
2026-10-0550$39.53$2K
2026-10-0250$39.31$2K
2026-09-3050$39.81$2K
2026-09-25443,776$40.22$17.8M
2026-09-2445,509$39.01$1.8M
2026-09-23844$39.52$33K
2026-09-2218,519$40.06$742K
2026-09-213,768$38.98$147K
2026-09-18183$39.19$7K
2026-09-175,673$38.53$219K
2026-09-165,371$39.25$211K
2026-09-15201,448$38.72$7.8M
2026-09-1412,764$37.09$473K
2026-09-09364$36.76$13K
2026-09-0466$36.62$2K
2026-09-02144$36.19$5K
2026-09-011,611$36.05$58K
2026-08-267,094$38.10$270K
2026-08-24142,931$37.34$5.3M
2026-08-218,026$36.81$295K
2026-08-19156$36.58$6K
2026-08-18780$36.46$28K
2026-08-1796$36.77$4K
2026-08-12907$36.48$33K
2026-08-04177$34.46$6K
2026-08-03588$35.01$21K
2026-07-2326,824$30.15$809K

Insider trades

SEC Form 4, newest first. JSON

Insiders at TEVA reported 18 open-market sells worth $33.9M in the last 90 days and no open-market buys. Latest filing: Sabag Mark (See "Remarks") on 2026-11-12.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-11-12Sabag MarkSee "Remarks"Sell45K$44.14$2.0M81K
2026-11-12Sabag MarkSee "Remarks"Exercise or conversion45K$34.90$1.6M125K
2026-11-11Daniell RichardEVP, Europe CommercialSell20K$42.80$856K56K
2026-11-11Daniell RichardEVP, Europe CommercialExercise or conversion20K$34.70$694K76K
2026-11-10Francis Richard DPresident and CEOSell250K$42.24$10.6M928K
2026-11-09Weiss AmirChief Accounting OfficerSell10K$43.03$410K4K
2026-11-09Weiss AmirChief Accounting OfficerSell7K$43.03$305K13K
2026-11-09Weiss AmirChief Accounting OfficerSell662$43.15$29K20K
2026-11-09Weiss AmirChief Accounting OfficerExercise or conversion8K$34.70$269K21K
2026-11-09Daniell RichardEVP, Europe CommercialSell25K$42.91$1.1M56K
2026-11-09Daniell RichardEVP, Europe CommercialExercise or conversion25K$34.70$868K81K
2026-11-05Sabag MarkSee "Remarks"Sell46K$41.93$1.9M81K
2026-11-05Sabag MarkSee "Remarks"Exercise or conversion46K$34.90$1.6M127K
2026-11-04Bergwerk DovInterim Cheif Legal OfficerSell9K$41.72$365K12K
2026-11-04Bergwerk DovInterim Cheif Legal OfficerExercise or conversion9K$28.98$254K21K
2026-11-04Bergwerk DovInterim Cheif Legal OfficerSell18K$41.72$730K12K
2026-11-04Bergwerk DovInterim Cheif Legal OfficerExercise or conversion18K$34.70$607K29K
2026-09-18Savage BrianInterim Chief Legal OfficerSell314$38.70$12K9K
2026-09-18Savage BrianInterim Chief Legal OfficerSell3K$39.15$99K9K
2026-09-18Savage BrianInterim Chief Legal OfficerSell5K$38.69$174K11K
2026-09-18Savage BrianInterim Chief Legal OfficerExercise or conversion5K$34.70$156K16K
2026-09-18MIGNONE ROBERTODirectorSell368K$39.06$14.4M0
2026-08-21Weiss AmirChief Accounting OfficerSell3K$37.63$94K13K
2026-08-21Weiss AmirChief Accounting OfficerExercise or conversion3K$19.61$49K16K
2026-08-21Weiss AmirChief Accounting OfficerSell7K$37.61$261K13K
2026-08-21Satchi-Fainaro RonitDirectorSell415$37.25$15K112K
2026-08-17Lippman EvanEVP, Business DevelopmentSell19K$36.57$680K26K
2026-08-05Zaks Tal ZviDirectorSell17$34.87$59373K
2026-08-03Hughes Eric ASee "Remarks"Sell26K$34.88$892K135K
2026-08-03Hughes Eric ASee "Remarks"Exercise or conversion53Kprice not stated in the filingnot stated160K
2026-08-03Jover PlacidSee "Remarks"Sell13K$34.88$447K7K
2026-08-03Jover PlacidSee "Remarks"Exercise or conversion13Kprice not stated in the filingnot stated20K
2026-06-18Shields MatthewEVP, Global OperationsSell10K$32.19$322K0
2026-06-11Kalif Eliyahu SharonEVP, Chief Financial OfficerSell107K$34.10$3.6M66K
2026-06-05Francis Richard DPresident and CEOExercise or conversion13Kprice not stated in the filingnot stated1.2M
2026-06-05Francis Richard DPresident and CEOSell6K$34.35$211K1.2M
2026-06-05MIGNONE ROBERTODirectorExercise or conversion14Kprice not stated in the filingnot stated120K
2026-06-05Zaks Tal ZviDirectorExercise or conversion14Kprice not stated in the filingnot stated73K
2026-06-05Satchi-Fainaro RonitDirectorExercise or conversion14Kprice not stated in the filingnot stated112K
2026-06-05Nisen PerryDirectorExercise or conversion14Kprice not stated in the filingnot stated120K
2026-06-05LIEBERMAN GERALD MDirectorExercise or conversion14Kprice not stated in the filingnot stated130K
2026-06-05Elstein AmirDirectorExercise or conversion14Kprice not stated in the filingnot stated2.1M
2026-06-05Crane Rosemary ADirectorExercise or conversion14Kprice not stated in the filingnot stated128K
2026-06-05Lichtenstein ChenDirectorExercise or conversion14Kprice not stated in the filingnot stated19K
2026-06-05BARER SOL JDirectorExercise or conversion22Kprice not stated in the filingnot stated448K
2026-06-03Shields MatthewEVP, Global OperationsSell16K$32.87$532K10K
2026-06-03Shields MatthewEVP, Global OperationsExercise or conversion16Kprice not stated in the filingnot stated26K
2026-05-14Lippman EvanEVP, Business DevelopmentSell36K$35.58$1.3M44K
2026-05-14Lippman EvanEVP, Business DevelopmentExercise or conversion12Kprice not stated in the filingnot stated12K
2026-05-14Lippman EvanEVP, Business DevelopmentSell6K$35.58$204K6K
2026-05-14Lippman EvanEVP, Business DevelopmentExercise or conversion74Kprice not stated in the filingnot stated80K
2026-05-14Kalif Eliyahu SharonEVP, Chief Financial OfficerSell153K$35.61$5.5M172K
2026-05-06Weiss AmirChief Accounting OfficerSell11K$36.00$384K20K
2026-05-05Daniell RichardEVP, Europe CommercialSell30K$35.40$1.1M56K
2026-05-01Sabag MarkSee "Remarks"Sell144K$34.99$5.0M81K
2026-04-30Fox ChristineEVP, U.S. CommercialSell21K$35.31$751K64K
2026-03-17Sabag MarkSee "Remarks"Sell62K$30.14$1.9M225K
2026-03-05Shields MatthewEVP, Global OperationsExercise or conversion17Kprice not stated in the filingnot stated27K
2026-03-05Shields MatthewEVP, Global OperationsSell17K$31.67$548K10K
2026-03-05Savage BrianInterim Chief Legal OfficerSell1K$31.67$36K11K
2026-03-05Savage BrianInterim Chief Legal OfficerExercise or conversion4Kprice not stated in the filingnot stated12K
2026-03-05Jover Placid"See ""Remarks"""Exercise or conversion14Kprice not stated in the filingnot stated21K
2026-03-05Jover Placid"See ""Remarks"""Sell14K$31.67$448K7K
2026-03-05Daniell RichardEVP, Europe CommercialExercise or conversion17Kprice not stated in the filingnot stated103K
2026-03-05Daniell RichardEVP, Europe CommercialSell17K$31.67$548K86K
2026-03-05Hughes Eric A"See ""Remarks"""Sell10K$31.67$302K108K
2026-03-05Hughes Eric A"See ""Remarks"""Exercise or conversion20Kprice not stated in the filingnot stated117K
2026-03-05Fox ChristineEVP, U.S. CommercialExercise or conversion18Kprice not stated in the filingnot stated93K
2026-03-05Fox ChristineEVP, U.S. CommercialSell8K$31.67$251K85K
2026-03-05Francis Richard DPresident and CEOSell20K$31.67$634K1.2M
2026-03-05Francis Richard DPresident and CEOExercise or conversion42Kprice not stated in the filingnot stated1.2M
2026-03-05Weiss AmirChief Accounting OfficerExercise or conversion4Kprice not stated in the filingnot stated31K
2026-03-05Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion20Kprice not stated in the filingnot stated325K
2026-03-05Sabag Mark"See ""Remarks"""Exercise or conversion16Kprice not stated in the filingnot stated287K
2026-03-04Weiss AmirChief Accounting OfficerExercise or conversion11Kprice not stated in the filingnot stated22K
2026-03-04Weiss AmirChief Accounting OfficerExercise or conversion6Kprice not stated in the filingnot stated27K
2026-03-04Savage BrianInterim Chief Legal OfficerExercise or conversion3Kprice not stated in the filingnot stated10K
2026-03-04Savage BrianInterim Chief Legal OfficerSell1K$32.46$48K6K
2026-03-04Savage BrianInterim Chief Legal OfficerExercise or conversion5Kprice not stated in the filingnot stated8K
2026-03-04Savage BrianInterim Chief Legal OfficerSell1K$32.46$38K8K
2026-03-04Fox ChristineEVP, U.S. CommercialSell9K$32.46$295K75K
2026-03-04Fox ChristineEVP, U.S. CommercialExercise or conversion20Kprice not stated in the filingnot stated84K
2026-03-04Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion34Kprice not stated in the filingnot stated282K
2026-03-04Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion23Kprice not stated in the filingnot stated306K
2026-03-04Hughes Eric A"See ""Remarks"""Sell11K$32.46$366K98K
2026-03-04Hughes Eric A"See ""Remarks"""Exercise or conversion23Kprice not stated in the filingnot stated109K
2026-03-04Sabag Mark"See ""Remarks"""Exercise or conversion34Kprice not stated in the filingnot stated253K
2026-03-04Sabag Mark"See ""Remarks"""Exercise or conversion19Kprice not stated in the filingnot stated271K
2026-03-04Daniell RichardEVP, Europe CommercialSell20K$32.46$664K123K
2026-03-04Daniell RichardEVP, Europe CommercialSell37K$32.95$1.2M86K
2026-03-04Daniell RichardEVP, Europe CommercialExercise or conversion34Kprice not stated in the filingnot stated157K
2026-03-04Daniell RichardEVP, Europe CommercialSell34K$32.46$1.1M123K
2026-03-04Daniell RichardEVP, Europe CommercialExercise or conversion20Kprice not stated in the filingnot stated144K
2026-03-04Francis Richard DPresident and CEOSell23K$32.46$759K1.1M
2026-03-04Francis Richard DPresident and CEOExercise or conversion50Kprice not stated in the filingnot stated1.2M
2026-03-03Hughes Eric A"See ""Remarks"""Sell69K$32.36$2.2M86K
2026-03-03Hughes Eric A"See ""Remarks"""Exercise or conversion25Kprice not stated in the filingnot stated25K
2026-03-03Hughes Eric A"See ""Remarks"""Sell12K$32.36$391K13K
2026-03-03Hughes Eric A"See ""Remarks"""Exercise or conversion141Kprice not stated in the filingnot stated154K
2026-03-03Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion50Kprice not stated in the filingnot stated107K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

45 Form 144 notices on file for TEVA worth $131.4M at the prices reported; 9 in the last 90 days worth $33.0M. Latest: Sabag Mark filed on 2026-11-12 to sell 44,710 shares ($2.0M) from 2026-11-12.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-11-12Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL45K$2.0M0.004%2026-11-12CITIGROUP GLOBAL MARKETS INC
2026-11-12Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL20K$856K0.002%2026-11-11CITIGROUP GLOBAL MARKETS INC
2026-11-10Francis Richard D.Officer250K$10.7M0.021%2026-11-10Societe Generale Private Banking (Monaco)
2026-11-09Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL25K$1.1M0.002%2026-11-09CITIGROUP GLOBAL MARKETS INC
2026-11-05Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL46K$1.9M0.004%2026-11-05CITIGROUP GLOBAL MARKETS INC
2026-11-04Bergwerk DovSenior VP General Counsel Corporate Secretary26K$1.1M0.002%2026-11-04Citigroup Global Markets, Inc
2026-09-21Savage BrianOfficer, CHIEF LEGAL OFFICER7K$273K0.000%2026-09-18CITIGROUP GLOBAL MARKETS
2026-09-18Bridger Management, LLC (1)Shareholder368K$14.4M0.032%2026-09-18Apex Clearing Corporation
2026-08-17Lippman EvanOfficer, EVP BUSINESS DEVELOPMENT19K$680K0.002%2026-08-17CITIGROUP GLOBAL MARKETS
2026-08-03Jover PlacidExecutive VP, Chief HR Officer13K$447K0.001%2026-08-03Citigroup Global Markets, Inc
2026-08-03Hughes Eric AExecutive VP Global R&amp;D and Chief Med Officer26K$892K0.002%2026-08-03Citigroup Global Markets, Inc
2026-06-18Shields MatthewOfficer, EXECUTIVE VP TEVA GLOBAL OPERATIONS10K$322K0.001%2026-06-18CITIGROUP GLOBAL MARKETS
2026-06-11Kalif Eliyahu SharonOfficer, EVP CHIEF FINANCIAL OFFICER107K$3.6M0.009%2026-06-11CITIGROUP GLOBAL MARKETS
2026-06-05Francis Richard DOfficer, PRESIDENT AND CEO6K$211K0.001%2026-06-05CITIGROUP GLOBAL MARKETS INC
2026-06-03Shields MatthewOfficer, EXECUTIVE VP TEVA GLOBAL OPERATIONS16K$532K0.001%2026-06-03CITIGROUP GLOBAL MARKETS
2026-05-14Lippman EvanOfficer, EXECUTIVE VP BUSINESS DEVELOPMENT42K$1.5M0.004%2026-05-14CITIGROUP GLOBAL MARKETS
2026-05-14Kalif Eliyahu SharonOfficer, EVP CHIEF FINANCIAL OFFICER153K$5.5M0.013%2026-05-14CITIGROUP GLOBAL MARKETS
2026-05-05Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL30K$1.1M0.003%2026-05-05CITIGROUP GLOBAL MARKETS INC
2026-05-04Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL144K$5.0M0.012%2026-05-01CITIGROUP GLOBAL MARKETS INC
2026-03-17Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL62K$1.9M0.005%2026-03-17CITIGROUP GLOBAL MARKETS INC
2026-03-05Shields MatthewOfficer, EXECUTIVE VP TEVA GLOBAL OPERATIONS17K$548K0.002%2026-03-05CITIGROUP GLOBAL MARKETS
2026-03-05Savage BrianOfficer, INTERIM CHIEF LEGAL OFFICER1K$36K0.000%2026-03-05CITIGROUP GLOBAL MARKETS
2026-03-05Jover PlacidOfficer, EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER14K$448K0.001%2026-03-05CITIGROUP GLOBAL MARKETS
2026-03-05Hughes Eric AOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER10K$302K0.001%2026-03-05CITIGROUP GLOBAL MARKETS
2026-03-05Francis Richard DOfficer, PRESIDENT AND CEO20K$634K0.002%2026-03-05CITIGROUP GLOBAL MARKETS INC
2026-03-05Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL8K$251K0.001%2026-03-05CITIGROUP GLOBAL MARKETS INC
2026-03-05Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL17K$548K0.002%2026-03-05CITIGROUP GLOBAL MARKETS INC
2026-03-04Hughes Eric AOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER11K$366K0.001%2026-03-04CITIGROUP GLOBAL MARKETS
2026-03-04Francis Richard DOfficer, PRESIDENT AND CEO23K$759K0.002%2026-03-04CITIGROUP GLOBAL MARKETS INC
2026-03-04Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL10K$322K0.001%2026-03-04CITIGROUP GLOBAL MARKETS INC
2026-03-04Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL91K$3.0M0.008%2026-03-04CITIGROUP GLOBAL MARKETS INC
2026-03-03Savage BrianOfficer, EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER1K$41K0.000%2026-03-03CITIGROUP GLOBAL MARKETS
2026-03-03Hughes Eric AOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER81K$2.6M0.007%2026-03-03CITIGROUP GLOBAL MARKETS
2026-03-03Francis Richard DOfficer, PRESIDENT AND CEO443K$14.3M0.039%2026-03-03CITIGROUP GLOBAL MARKETS INC
2026-03-03Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL129K$4.2M0.011%2026-03-03CITIGROUP GLOBAL MARKETS INC
2026-02-26Kalif Eliyahu SharonOfficer, EVP CHIEF FINANCIAL OFFICER346K$11.6M0.030%2026-02-26CITIGROUP GLOBAL MARKETS
2026-02-18Francis Richard DOfficer, PRESIDENT AND CEO448K$15.3M0.039%2026-02-17CITIGROUP GLOBAL MARKETS
2026-02-18Francis Richard DOfficer, PRESIDENT AND CEO448K$448K2.922%2026-02-17CITIGROUP GLOBAL MARKETS INC
2025-12-12Bridger Management, LLC (1)Shareholder150K$4.5M0.013%2025-12-12Piper Sandler & Co.
2025-12-09Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL217K$6.2M0.019%2025-12-09CITIGROUP GLOBAL MARKETS INC
2025-12-09Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL115K$3.3M0.010%2025-12-09CITIGROUP GLOBAL MARKETS INC
2025-11-26Bridger Management, LLC (1)Shareholder50K$1.2M0.004%2025-11-26Piper Sandler & Co.
2025-11-20Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL28K$700K0.002%2025-11-20CITIGROUP GLOBAL MARKETS INC
2025-11-14Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL30K$753K0.003%2025-11-14CITIGROUP GLOBAL MARKETS INC
2025-11-06Bridger Management, LLC (1)Shareholder200K$4.9M0.017%2025-11-06Piper Sandler & Co.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

2 holders report 5% or more of TEVA in their latest filing, all on Schedule 13G (passive). The largest reported stake is Harel Insurance Investments & Financial Services Ltd. at 6.0% of the class (70,418,201 shares), filed 2026-11-02 for an event on 2026-09-30.

FiledFormHolderSharesOf classEvent
2026-11-1013G/Ano. 1MENORA MIVTACHIM HOLDINGS LTD.corporation58.2M5.0%2026-11-05
2026-11-0213G/Ano. 2Harel Insurance Investments & Financial Services Ltd.corporation70.4M6.0%2026-09-30
2026-02-1713GMigdal Insurance & Financial Holdings Ltdcorporation61.7M5.4%2025-12-31
2025-11-0513G/Ano. 3FMR LLCparent holding company24.6M2.1%2025-09-30
2025-11-0513G/Ano. 3Abigail P. Johnsonindividual24.6M2.1%2025-09-30

13F holders

Tracked managers holding TEVA at their latest 13F. JSON

10 of the 30 tracked managers held TEVA at their latest 13F, $333.3M in total at quarter-end prices. Millennium Management is the largest at $110.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 4 cut.

FundQuarterSharesValueOf portfolioChange in shares
Millennium Management2026-06-303.3M$110.6M0.04%+1.4M
Greenlight Capital (DME Capital)2026-06-302.9M$97.8M2.50%-25K
Bridgewater Associates2026-06-301.3M$44.9M0.18%+198K
Point72 Asset Management2026-06-301.1M$35.9M0.04%-71K
Duquesne Family Office2026-06-30625K$21.2M0.41%-1.8M
Two Sigma Investments2026-06-30231K$7.8M0.01%-136K
D. E. Shaw & Co.2026-06-30181K$6.1M0.00%+41K
AQR Capital Management2026-06-30108K$3.6M0.00%+33K
ARK Investment Management2026-09-3068K$2.7M0.02%new
Citadel Advisors2026-06-3073K$2.5M0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q3 FY 2026 (quarter ended 2026-09-30) Teva Pharmaceutical Industries reported revenue of $4.39B, down 1.9% from the same quarter a year earlier, and net income of $233.0M (0.20 diluted EPS). In FY 2025 it generated $1.65B of operating cash flow. As of 2026-09-30, cash was $4.08B against $4.04B of debt.

Cash
$4.08B
Debt
$4.04B
Equity
$7.98B
Total assets
$40.04B
Shares outstanding
1,166,826,784

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q3 FY 20262026-09-30$4.39B$233.0M5.3%0.20
Q2 FY 20262026-06-30$4.14B-$576.0M-13.9%-0.49
Q1 FY 20262026-03-31$3.98B$369.0M9.3%0.31
Q4 FY 20252025-12-31$1.50Bn/an/an/a
Q3 FY 20252025-09-30$4.48B$433.0M9.7%0.37
Q2 FY 20252025-06-30$4.18B$282.0M6.8%0.24
Q1 FY 20252025-03-31$3.89B$214.0M5.5%0.18
Q4 FY 2024derived2024-12-31$4.23B-$217.0M-5.1%n/a

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$17.26B$1.41B$1.65B$501.0Mn/an/a
FY 20242024-12-31$16.54B-$1.64B$1.25B$498.0Mn/an/a
FY 20232023-12-31$15.85B-$559.0M$1.37B$526.0Mn/an/a
FY 20222022-12-31$14.93B-$2.45B$1.59B$548.0Mn/an/a
FY 20212021-12-31$15.88B$417.0M$798.0M$562.0Mn/an/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30; shares outstanding as of 2026-09-30 from the cover page.

What this page is

Teva Pharmaceutical Industries in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Teva Pharmaceutical Industries (TEVA), SEC CIK 818686, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-12.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-11-12.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-11-10.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-11-03.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-11-12.JSON and CSV
Company record
EDGAR filing index for CIK 818686Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of TEVA is sold short?
27,739,194 shares were held short at the 2026-10-30 settlement, 5.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is TEVA's daily short volume?
On 2026-11-12, 805,148 of the 4,191,512 TEVA shares reported to FINRA were sold short, 19.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does TEVA have fails to deliver?
The SEC's latest file shows 1,209 TEVA shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are TEVA insiders buying or selling?
Insiders at TEVA reported 18 open-market sells worth $33.9M in the last 90 days and no open-market buys. Latest filing: Sabag Mark (See "Remarks") on 2026-11-12.
Have TEVA insiders filed to sell?
45 Form 144 notices on file for TEVA worth $131.4M at the prices reported; 9 in the last 90 days worth $33.0M. Latest: Sabag Mark filed on 2026-11-12 to sell 44,710 shares ($2.0M) from 2026-11-12.
Who owns 5% or more of TEVA?
2 holders report 5% or more of TEVA in their latest filing, all on Schedule 13G (passive). The largest reported stake is Harel Insurance Investments & Financial Services Ltd. at 6.0% of the class (70,418,201 shares), filed 2026-11-02 for an event on 2026-09-30.
What did TEVA report last quarter?
In Q3 FY 2026 (quarter ended 2026-09-30) Teva Pharmaceutical Industries reported revenue of $4.39B, down 1.9% from the same quarter a year earlier, and net income of $233.0M (0.20 diluted EPS). In FY 2025 it generated $1.65B of operating cash flow. As of 2026-09-30, cash was $4.08B against $4.04B of debt.
Which tracked 13F managers own TEVA?
10 of the 30 tracked 13F managers held TEVA shares at their latest filing, $333.3M in all. The largest: Izzy Englander's Millennium Management (3.3M shares, $110.6M), David Einhorn's Greenlight Capital (DME Capital) (2.9M shares, $97.8M), Ray Dalio's Bridgewater Associates (1.3M shares, $44.9M), Steve Cohen's Point72 Asset Management (1.1M shares, $35.9M), Stanley Druckenmiller's Duquesne Family Office (625K shares, $21.2M), Two Sigma Investments (231K shares, $7.8M). The table above lists all 10.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.